Clinical Trial

EUS- and US- Guided Biopsy for Pancreatic Lesion

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 24, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Endoscopic ultrasound (EUS) and ultrasound (US) are the two primary imaging modalities used to guide pancreatic needle biopsy. This study aimed to compare the diagnostic performance and complications associated with EUS- and US-guided pancreatic biopsies.
Trial Details
NCT Number NCT07138976
Lead Sponsor Tian'an Jiang
Conditions Pancreatic Cancer
Enrollment 2,517 participants
Start Date 2025-08-18
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-24